Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. | CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. | Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. | Rakuten Medical Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies. | |
Founding Date | Founding Date 2011 | Founding Date 2008 | Founding Date 2008 | Founding Date 2015 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Austin, US HQ Montréal, CA | Locations South San Francisco, US HQ | Locations Cambridge, US HQ | Locations Redwood City, US HQ | Locations San Diego, US HQ Setagaya City, JP Amsterdam, NL Ecublens, CH Taipei, TW Taipei, TW San Mateo, US |
Employees | Employees 811% decrease | Employees 15815% increase | Employees 53611% increase | Employees 943% increase | Employees 1212% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 78 m | Valuation ($) 2.7 b | Valuation ($) 25.6 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $101.2m (FY, 2023) | Revenue (est.) $26.8m (FY, 2023) | Revenue (est.) $7.9m (FY, 2023) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($569k) (FY, 2023) | Net income ($352.1m) (FY, 2023) | Net income ($69.2m) (FY, 2023) | Net income N/A |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) 13 (FY, 2016) | Patents (US) N/A | Patents (US) 1 (FY, 2020) | Patents (US) N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 132.4m | Total funding raised N/A | Total funding raised $ 177.5m | Total funding raised $ 451.9m |